Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma

There are seven mammalian isoforms of the 14-3-3 protein, which regulate multiple cellular functions via interactions with phosphorylated partners. Increased expression of 14-3-3 proteins contributes to tumor progression of various malignancies. Several isoforms of 14-3-3 are overexpressed and assoc...

Full description

Bibliographic Details
Main Authors: Yi-Ju Wu, Yee-Jee Jan, Bor-Sheng Ko, Shu-Man Liang, Jun-Yang Liou
Format: Article
Language:English
Published: MDPI AG 2015-06-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/7/2/0822
_version_ 1797761762236301312
author Yi-Ju Wu
Yee-Jee Jan
Bor-Sheng Ko
Shu-Man Liang
Jun-Yang Liou
author_facet Yi-Ju Wu
Yee-Jee Jan
Bor-Sheng Ko
Shu-Man Liang
Jun-Yang Liou
author_sort Yi-Ju Wu
collection DOAJ
description There are seven mammalian isoforms of the 14-3-3 protein, which regulate multiple cellular functions via interactions with phosphorylated partners. Increased expression of 14-3-3 proteins contributes to tumor progression of various malignancies. Several isoforms of 14-3-3 are overexpressed and associate with higher metastatic risks and poorer survival rates of hepatocellular carcinoma (HCC). 14-3-3β and 14-3-3ζ regulate HCC cell proliferation, tumor growth and chemosensitivity via modulating mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK) and p38 signal pathways. Moreover, 14-3-3ε suppresses E-cadherin and induces focal adhesion kinase (FAK) expression, thereby enhancing epithelial-mesenchymal transition (EMT) and HCC cell migration. 14-3-3ζ forms complexes with αB-crystallin, which induces EMT and is the cause of sorafenib resistance in HCC. Finally, a recent study has indicated that 14-3-3σ induces heat shock protein 70 (HSP70) expression, which increases HCC cell migration. These results suggest that selective 14-3-3 isoforms contribute to cell proliferation, EMT and cell migration of HCC by regulating distinct targets and signal pathways. Targeting 14-3-3 proteins together with specific downstream effectors therefore has potential to be therapeutic and prognostic factors of HCC. In this article, we will overview 14-3-3's regulation of its downstream factors and contributions to HCC EMT, cell migration and proliferation.
first_indexed 2024-03-12T19:17:44Z
format Article
id doaj.art-2d871ce8efe34bbea7dbc1cab01b7a6c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T19:17:44Z
publishDate 2015-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-2d871ce8efe34bbea7dbc1cab01b7a6c2023-08-02T05:24:35ZengMDPI AGCancers2072-66942015-06-01721022103610.3390/cancers7020822cancers7020822Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular CarcinomaYi-Ju Wu0Yee-Jee Jan1Bor-Sheng Ko2Shu-Man Liang3Jun-Yang Liou4Institute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan 350, TaiwanDepartment of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung 407, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei 100, TaiwanInstitute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan 350, TaiwanInstitute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan 350, TaiwanThere are seven mammalian isoforms of the 14-3-3 protein, which regulate multiple cellular functions via interactions with phosphorylated partners. Increased expression of 14-3-3 proteins contributes to tumor progression of various malignancies. Several isoforms of 14-3-3 are overexpressed and associate with higher metastatic risks and poorer survival rates of hepatocellular carcinoma (HCC). 14-3-3β and 14-3-3ζ regulate HCC cell proliferation, tumor growth and chemosensitivity via modulating mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK) and p38 signal pathways. Moreover, 14-3-3ε suppresses E-cadherin and induces focal adhesion kinase (FAK) expression, thereby enhancing epithelial-mesenchymal transition (EMT) and HCC cell migration. 14-3-3ζ forms complexes with αB-crystallin, which induces EMT and is the cause of sorafenib resistance in HCC. Finally, a recent study has indicated that 14-3-3σ induces heat shock protein 70 (HSP70) expression, which increases HCC cell migration. These results suggest that selective 14-3-3 isoforms contribute to cell proliferation, EMT and cell migration of HCC by regulating distinct targets and signal pathways. Targeting 14-3-3 proteins together with specific downstream effectors therefore has potential to be therapeutic and prognostic factors of HCC. In this article, we will overview 14-3-3's regulation of its downstream factors and contributions to HCC EMT, cell migration and proliferation.http://www.mdpi.com/2072-6694/7/2/082214-3-3apoptosisepithelial-mesenchymal transitionhepatocellular carcinomamigrationproliferation
spellingShingle Yi-Ju Wu
Yee-Jee Jan
Bor-Sheng Ko
Shu-Man Liang
Jun-Yang Liou
Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
Cancers
14-3-3
apoptosis
epithelial-mesenchymal transition
hepatocellular carcinoma
migration
proliferation
title Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
title_full Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
title_fullStr Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
title_full_unstemmed Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
title_short Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
title_sort involvement of 14 3 3 proteins in regulating tumor progression of hepatocellular carcinoma
topic 14-3-3
apoptosis
epithelial-mesenchymal transition
hepatocellular carcinoma
migration
proliferation
url http://www.mdpi.com/2072-6694/7/2/0822
work_keys_str_mv AT yijuwu involvementof1433proteinsinregulatingtumorprogressionofhepatocellularcarcinoma
AT yeejeejan involvementof1433proteinsinregulatingtumorprogressionofhepatocellularcarcinoma
AT borshengko involvementof1433proteinsinregulatingtumorprogressionofhepatocellularcarcinoma
AT shumanliang involvementof1433proteinsinregulatingtumorprogressionofhepatocellularcarcinoma
AT junyangliou involvementof1433proteinsinregulatingtumorprogressionofhepatocellularcarcinoma